ConductScience.org, home

Paper41314865

Pharmacokinetic assessment of elexacaftor/tezacaftor/ivacaftor and their metabolites in maternal blood, cord blood, the neonate, and breastmilk of a cystic fibrosis carrier mother/affected fetus dyad.

Sinkey RG and 6 others. J Cyst Fibros, 2026. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Pharmacokinetic assessment of elexacaftor/tezacaftor/ivacaftor and their metabolites in maternal blood, cord blood, the neonate, and breastmilk of a cystic fibrosis carrier mother/affected fetus dyad. Papers, record 41314865. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41314865

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacokinetic assessment of elexacaftor/tezacaftor/ivacaftor and their metabolites in maternal blood, cord blood, the neonate, and breastmilk of a cystic fibrosis carrier mother/affected fetus dyad.
PubMed
Journal
J Cyst Fibros
PubMed
Year
2026
PubMed
Publication types
Case Reports, Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-09-19
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sinkey RGRachel G
2Garcia BBryan
3Fowler CMChristopher Miles
4Krick SStefanie
5Ryan KJKevin J
6Acosta EPEdward P
7Guimbellot JSJennifer S

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cystic FibrosisMajor topic
AminophenolsMajor topic
Fetal BloodMajor topic
Milk, HumanMajor topic
QuinolonesMajor topic
BenzodioxolesMajor topic
IndolesMajor topic
PyrazolesMajor topic
PhenylpropionatesMajor topic
PyridinesMajor topic
PyrrolidinesMajor topic
Humans
Female
Pregnancy
Infant, Newborn
Drug Combinations
Adult
Chloride Channel Agonists
Cystic Fibrosis Transmembrane Conductance Regulator
Quinolines

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
K23 HL159331NHLBI NIH HHSUnited StatesK23HL159331PubMedNIH RePORTER
R01 HD117940NICHD NIH HHSUnited StatesR01HD117940PubMedNIH RePORTER

Download CSV of grants

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135440408Current prices versus minimum costs of production for CFTR modulators.J Cyst Fibros2022https://conductscience.org/library/papers/35440408PubMed
241037817Pregnancy in Patients With Cystic Fibrosis.Obstet Gynecol2026https://conductscience.org/library/papers/41037817PubMed
338876833Clinical outcomes of two infants with cystic fibrosis, including presence of the vas deferens, born to a woman with cystic fibrosis taking CFTR modulators during both pregnancies.J Cyst Fibros2024https://conductscience.org/library/papers/38876833PubMed
439666984Pregnancy in People With Cystic Fibrosis Treated With Highly Effective Modulator Therapy.Obstet Gynecol2025https://conductscience.org/library/papers/39666984PubMed
540399734Pharmacokinetics of Ivacaftor, Tezacaftor, Elexacaftor, and Lumacaftor in Special Cystic Fibrosis Populations: A Systematic Review.Clin Pharmacokinet2025https://conductscience.org/library/papers/40399734PubMed
640121139Elexacaftor-tezacaftor-ivacaftor pharmacokinetics with concurrent tacrolimus administration after lung transplant.J Cyst Fibros2025https://conductscience.org/library/papers/40121139PubMed
725455573Maternal medication, drug use, and breastfeeding.Child Adolesc Psychiatr Clin N Am2015https://conductscience.org/library/papers/25455573PubMed
836371965Quantitation of cystic fibrosis triple combination therapy, elexacaftor/tezacaftor/ivacaftor, in human plasma and cellular lysate.J Chromatogr B Analyt Technol Biomed Life Sci2022https://conductscience.org/library/papers/36371965PubMed
940133101First real-world study of fetal therapy with CFTR modulators in cystic fibrosis: Report from the MODUL-CF study.J Cyst Fibros2025https://conductscience.org/library/papers/40133101PubMed
1038964603Differential distribution of ivacaftor and its metabolites in plasma and human airway epithelia.Pulm Pharmacol Ther2024https://conductscience.org/library/papers/38964603PubMed
1138232663Fetal drug exposure after maternally administered CFTR modulators Elexacaftor/Tezacaftor/Ivacaftor in a rat model.Biomed Pharmacother2024https://conductscience.org/library/papers/38232663PubMed
1233846105Normal pancreatic function and false-negative CF newborn screen in a child born to a mother taking CFTR modulator therapy during pregnancy.J Cyst Fibros2021https://conductscience.org/library/papers/33846105PubMed
1336996799Prenatal Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy: A Promising Way to Change the Impact of Cystic Fibrosis.Fetal Diagn Ther2023https://conductscience.org/library/papers/36996799PubMed
1439645477Outcomes of prenatal use of elexacaftor/tezacaftor/ivacaftor in carrier mothers to treat meconium ileus in fetuses with cystic fibrosis.J Cyst Fibros2025https://conductscience.org/library/papers/39645477PubMed
1535422395A case report of CFTR modulator administration via carrier mother to treat meconium ileus in a F508del homozygous fetus.J Cyst Fibros2022https://conductscience.org/library/papers/35422395PubMed
1637690692Elexacaftor/VX-445-mediated CFTR interactome remodeling reveals differential correction driven by mutation-specific translational dynamics.J Biol Chem2023https://conductscience.org/library/papers/37690692PubMed
1740118755CFTR modulator therapy via carrier mother to treat meconium ileus in a F508del homozygous fetus: Insights from an unsuccessful case.J Cyst Fibros2025https://conductscience.org/library/papers/40118755PubMed
1834952795Drug exposure to infants born to mothers taking Elexacaftor, Tezacaftor, and Ivacaftor.J Cyst Fibros2022https://conductscience.org/library/papers/34952795PubMed

Download CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn Papers
42819752Prenatal CFTR modulator therapy for fetal cystic fibrosis: Emerging evidence, clinical considerations, and future directions.Pregnancy (Hoboken)2026https://conductscience.org/library/papers/42819752

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41314865

GET https://conductscience.org/api/papers/v1/41314865/authors